S, C., E, M., S, P., L, P., C, M., M, O., . . . QG, D. (2026). A methylome-based score to predict survival after regorafenib in recurrent glioblastoma. Neuro-oncology advances, 8(1), vdag108. https://doi.org/10.1093/noajnl/vdag108
Chicago Style (17th ed.) CitationS, Chiesa, et al. "A Methylome-based Score to Predict Survival After Regorafenib in Recurrent Glioblastoma." Neuro-oncology Advances 8, no. 1 (2026): vdag108. https://doi.org/10.1093/noajnl/vdag108.
MLA (9th ed.) CitationS, Chiesa, et al. "A Methylome-based Score to Predict Survival After Regorafenib in Recurrent Glioblastoma." Neuro-oncology Advances, vol. 8, no. 1, 2026, p. vdag108, https://doi.org/10.1093/noajnl/vdag108.
Warning: These citations may not always be 100% accurate.